As of October 27 at 11:21:49 AM GMT. Market Open. Get top stock picks Research reports are not currently available for PEMB.L.

Altimmune’s latest earnings call struck an upbeat tone, with management leaning on robust Phase II liver data, a coveted FDA Breakthrough Therapy designation, and a fortified balance sheet that ...

Pembroke VCT plc (the "Company") has today published a prospectus (the "Prospectus") in relation to the offer for subscription of up to £40 million of B Ordinary Shares of 1p each in the capital of ...

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private investor ...